Skip to content
CALL: (800) 884-9600

Cancer and Social Security Disability Benefits

Site-specific Chapter 13.00 listings, treatment effects, and careful CAL verification

Last Updated September 17, 2026

Conditions Center · Cancer · Social Security Disability

Also called malignant neoplastic disease, malignancy.

Cancer may qualify for SSDI or SSI under a site- and type-specific Chapter 13.00 listing or through the combined effects of the disease and treatment. The analysis depends on the pathology, primary site, stage and spread, response to treatment, recurrence, and expected duration. “Cancer” by itself is too broad to identify the applicable listing or Compassionate Allowance status.

What is Cancer?

Cancer is a group of diseases in which abnormal cells grow without normal control and may invade nearby tissue or spread to distant parts of the body. Solid tumors and blood cancers differ substantially. Treatment may involve surgery, chemotherapy, radiation, hormone therapy, targeted therapy, immunotherapy, or stem-cell transplantation, with effects that vary by diagnosis and person.

Common symptoms of Cancer

  • Symptoms caused by the primary tumor or metastases
  • Pain, weakness, bleeding, or organ dysfunction depending on the site
  • Weight loss, reduced appetite, or cancer-related fatigue
  • Nausea, neuropathy, cognitive complaints, or infection risk from treatment
  • Reduced mobility or endurance after surgery or intensive therapy

How can Cancer affect a person’s ability to work?

  • Absences for treatment, monitoring, procedures, and recovery
  • Reduced stamina, pace, lifting, standing, or walking
  • Limited hand or foot use from treatment-related neuropathy
  • Concentration difficulty or slowed processing when documented
  • Restrictions related to infection risk, ostomy care, lymphedema, or affected organs

Does Social Security have a Listing for Cancer?

Whether a current listing directly names Cancer should be verified against the official Blue Book before anyone relies on a listing number. SSA may still evaluate the claim through medical equivalence or residual functional capacity.

Listing 13.00 is a chapter containing separate criteria for different malignant neoplastic diseases; it is not a single “cancer listing.” SSA considers the cancer’s origin, type, extent, treatment, recurrence, metastasis, and treatment effects under the applicable site-specific provision.

SSA selects the current Chapter 13.00 provision for the specific cancer rather than applying a generic cancer listing. The agency considers pathology and operative evidence, the primary site, spread, recurrence or persistence, and treatment. It may need to wait for an expected treatment response in situations described by the chapter. If no cancer listing is met or equaled, SSA evaluates residual disease, treatment effects, and other impairments in RFC.

Can you qualify if you do not meet an SSA Listing?

Yes. A malignancy that does not meet its specific Chapter 13.00 criteria may still support disability when disease and treatment effects produce an RFC that rules out sustained work.

What medical evidence may help document Cancer?

  • Pathology and cytology reports identifying the malignancy
  • Oncology notes with primary site, stage, spread, treatment plan, and response
  • Operative, radiation, infusion, and hospitalization records
  • Imaging and laboratory evidence used to monitor disease
  • Rehabilitation and specialist records documenting lasting treatment effects

Testing, imaging, and laboratory studies

  • Biopsy or other pathology evidence when medically obtained
  • Site-appropriate imaging and staging studies
  • Blood counts and organ-function monitoring during treatment
  • Molecular or tumor-marker testing when clinically relevant to the cancer

A current treatment calendar, side effects, postponements, dose changes, hospitalizations, and recovery between cycles are more useful than the statement “receiving chemotherapy.” After treatment, records should distinguish temporary recovery needs from lasting residual impairments.

How SSA may evaluate residual functional capacity

RFC must combine cancer-related symptoms with treatment effects and any lasting surgical or organ limitations. Attendance and recovery may be decisive during active treatment; neuropathy, fatigue, lymphedema, cognitive effects, or organ damage may persist afterward.

Physical RFC varies by cancer site and treatment and may address lifting, mobility, reaching, hand use, endurance, infection exposure, restroom access, or ostomy care.

Concentration, memory, anxiety, or depression should be evaluated when documented rather than assumed from the diagnosis.

Common issues that can weaken a disability claim involving Cancer

Using a general diagnosis without pathology; citing Chapter 13.00 as one listing; assuming every cancer is a CAL condition; or failing to document lasting limitations after treatment ends.

What may strengthen the medical documentation

Pathology, site-specific staging and spread evidence, a complete treatment timeline, documented side effects, and a clear post-treatment functional assessment allow the correct SSA pathway to be applied.

Cancer and related medical conditions

  • Breast CancerSSA evaluates breast cancer under Listing 13.10. Some distant, inoperable, or recurrent cases appear on the current Compassionate Allowances list; verify the exact presentation.
  • Chronic Kidney DiseaseCurrent Listing 6.00 includes separate pathways for ongoing dialysis, kidney transplant, impaired kidney function with complications, and repeated CKD hospitalizations.
  • Congestive Heart FailureChronic heart failure can reduce exertional capacity and cause fluid buildup. Listing 4.02 requires the specific medical and functional findings in the current cardiovascular rules.
  • Lung CancerSSA evaluates lung cancer under Listing 13.14. Small-cell carcinoma and some non-small-cell presentations also appear on the current Compassionate Allowances list; verify the exact histology and extent.
  • Lymphoma and LeukemiaSSA evaluates lymphoma under Listing 13.05 and leukemia under Listing 13.06. Some named blood cancers appear on the current CAL list; indolent or well-controlled disease is not automatically a CAL condition.
  • Major Depressive DisorderPersistent depressive symptoms may be evaluated under Listing 12.04. A diagnosis does not guarantee benefits; SSA also examines severity, duration, and work-related function.
  • Pancreatic CancerSSA evaluates pancreatic carcinoma under Listing 13.20. Pancreatic cancer appears on the current Compassionate Allowances list. Islet-cell carcinoma has a narrower listing pathway. A diagnosis still requires medical evidence.
  • Peripheral NeuropathyDamage to peripheral nerves that may cause pain, numbness, weakness, or balance problems. Listing 11.14 applies only when its specified functional criteria are met.

How Brock & Stout may help

We identify the site-specific Chapter 13.00 provision, verify rather than assume CAL status, gather oncology and pathology records, and develop an RFC for treatment or residual effects when the listing is not met.

Frequently asked questions

Related Brock & Stout resources

Speak with a Social Security Disability attorney

If Cancer is affecting your ability to work, Brock & Stout can review the claim, look for missing medical evidence, and discuss next steps. We do not charge a fee for SSD representation unless we win.

This page is general educational information about Social Security Disability as of the date of this publication. It is not legal or medical advice, does not create an attorney-client relationship, and does not guarantee results. Eligibility depends on individual facts and current Social Security rules.